Go Deep
Generate Biomedicines, Inc.
Generate Biomedicines, Inc. Score & Ratio Trend
| Date | Score | P/E | P/B | D/E | Price |
|---|---|---|---|---|---|
| Oct 2026 | 19,992 | -5.0 | 3.45 | 0.14 | 1,167.09 |
| Oct 2026 | 19,896 | -5.1 | 3.52 | 0.14 | 1,188.74 |
| Oct 2026 | 19,701 | -5.2 | 3.68 | 0.14 | 1,240.19 |
| Oct 2026 | 20,052 | -5.0 | 3.40 | 0.14 | 1,145.10 |
| Oct 2026 | 19,882 | -5.1 | 3.54 | 0.14 | 1,190.89 |
| Oct 2026 | 19,759 | -5.3 | 3.63 | 0.14 | 1,223.13 |
| Oct 2026 | 19,683 | -5.4 | 3.69 | 0.14 | 1,239.97 |
| Oct 2026 | 19,799 | -5.2 | 3.60 | 0.14 | 1,207.26 |
| Oct 2026 | 19,936 | -5.1 | 3.49 | 0.14 | 1,176.25 |
Generate Biomedicines, Inc. Quarterly Results
Quarterly data isn't available for this company right now.
Generate Biomedicines, Inc. Revenue & Profit
Annual financial data isn't available for this company right now.
Generate Biomedicines, Inc. Balance Sheet
Balance sheet data isn't available for this company right now.
Owes vs Owns
Generate Biomedicines, Inc. owed $0.19 for every $1 it owned in Jun 2026, down from $1.84 in Dec 2024.
| Period | Jun 2026 | Dec 2025 | Dec 2024 |
|---|---|---|---|
| Owes vs Owns | 0.19× | 2.89× | 1.84× |
Everything the company owes ÷ everything it owns. Below 1× it owns more than it owes; above 1× it owes more than it owns.
Generate Biomedicines, Inc. Cash Flow
Cash flow data isn't available for this company right now.